Commentary on rising drug prices and their impact on Switzerland

This commentary discusses how the pharmaceutical industry is exploiting pressure from the Trump administration to lobby for higher drug prices in Europe. It argues that this trend is detrimental to Switzerland and calls for the country to clarify its stance on the issue.